TAYLOR WEINTRAUB: Open Payments
NPI 1518521871 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,214 in 146 payments from 23 companies in 2025. Trend: 2023 $5,093 · 2024 $4,038 · 2025 $3,214
Food & beverage: $3,019Education: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $499 |
| GENZYME CORPORATION | 9 | $422 |
| UCB, Inc. | 17 | $335 |
| Lilly USA, LLC | 18 | $236 |
| Novartis Pharmaceuticals Corporation | 9 | $225 |
| Galderma Laboratories, L.P. | 15 | $207 |
| PFIZER INC. | 4 | $187 |
| Regeneron Healthcare Solutions, Inc. | 7 | $186 |
| Arcutis Biotherapeutics, Inc. | 15 | $183 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $151 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TALTZ, NEMLUVIO, Zoryve, RINVOQ, Rhapsido.
Industry payments across GA — which companies pay providers there.
